EMA Broadens Valsartan Contamination Investigation
The EMA expanded its investigation of valsartan impurities after a new contaminant was discovered in an Indian manufacturer’s active substance, losartan.
Source: Drug Industry Daily
The EMA expanded its investigation of valsartan impurities after a new contaminant was discovered in an Indian manufacturer’s active substance, losartan.
Source: Drug Industry Daily